U2Bio Co. Ltd. is a company based in South Korea, with its head office in Seoul. It operates in the Biological Product (except Diagnostic) Manufacturing industry. The enterprise was incorporated on April 12, 2026. 101 (2024) employees currently work for U2Bio Co. Ltd.. The latest financial highlights indicate a net sales revenue increase of 2.91% in Q3C2025. Over the same period, its total assets decreased by 5.73%. In 2025, U2Bio Co. Ltd.’s net profit margin decreased by 0.62%.

Headquarters
65, Geoma-Ro, Songpa-Gu
Seoul; Seoul;

Contact Details: Purchase the U2Bio Co. Ltd. report to view the information.

Website: http://www.u2bio.co.kr

Basic Information

Total Employees:

Purchase the U2Bio Co. Ltd. report to view the information.

Outstanding Shares:

Purchase the U2Bio Co. Ltd. report to view the information.

Financial Auditors:

Purchase the U2Bio Co. Ltd. report to view the information.

Incorporation Date:

April 12, 2026

Key Executives

Purchase this report to view the information.

Chief Executive Officer

Subsidiaries

(주)유투바이오

Company Performance

Financial values in the chart are available after U2Bio Co. Ltd. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.

Net sales revenue

2.91%▲

Total Operating Revenue

2.92%▲

Operating Profit

20.7%▲

EBITDA

29.56%▲

Net Profit/Loss for the Period

-17.76%▼

Total Assets

-5.73%▼

Total Equity

-8.25%▼

Operating Profit Margin

2.17%▲

Net Profit Margin

-0.62%▼

Return on Equity (ROE)

-0.64%▼

Debt / Equity

-99%▼

Quick Ratio

-157.21%▼

Cash Ratio

-2.31%▼

U2Bio Co. Ltd. (South Korea)

Similar companies